Tadalafil
- Strength
- 2.5 mg/1
- Form
- Tablet, Film Coated
- Class
- Phosphodiesterase 5 Inhibitor
Bostal LLC
Tadalafil
Listed by Eli Lilly and Company
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Phosphodiesterase 5 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0002-4462 |
| FDA application | NDA021368 |
| RxNorm concept | 402019 |
| Package sizes listed | 1 |
| Marketed since | November 2003 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Bostal LLC
Bostal LLC
Bostal LLC
Bostal LLC
Tadalafil
United Therapeutics Corporation
Tadalafil
Teva Pharmaceuticals, Inc.
Tadalafil
Eli Lilly and Company
Tadalafil
Eli Lilly and Company
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.